Edition:
India

People: Valneva SE (VLS.PA)

VLS.PA on Paris Stock Exchange

6.22EUR
3 Dec 2020
Change (% chg)

€0.05 (+0.81%)
Prev Close
€6.17
Open
€6.38
Day's High
€6.55
Day's Low
€6.03
Volume
477,352
Avg. Vol
537,156
52-wk High
€7.35
52-wk Low
€1.78

Lingelbach, Thomas 

Mr. Thomas Lingelbach serves as Chairman of the Management Board, President, Chief Executive Officer, Member of the Management Board of the Company. He previously served as Chairman of the Management Board and Executive Board, Co-President, Chief Executive Officer of Valneva SE as of 2012. He served at Intercell as of 2006, serving as COO until 2011 and then as its CEO. He joined Intercell from Novartis Vaccine & Diagnostics as Managing Director Germany focusing on the integration with Chiron Vaccine where he served as Vice President Global Industrial Operations and Managing Director Chiron-Behring. Mr. Lingelbach holds a Master's degree in Engineering and complemented his education with a Business Administration program. Currently he is Manager of Gratzelmixer GmbH, Director of Valneva UK and Valneva Canada as well as Chairman of Vaccines Holdings Sweden AB, among others.

Basic Compensation

Total Annual Compensation, EUR 660,730
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 38,532
Fiscal Year Total, EUR 699,262

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --